A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice
Clinical Genetics · 2025
DOI: 10.1111/cge.14634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Yaqi Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Receptor-Like Protein Tyrosine Phosphatases, Class 3, Hearing Loss. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Natural Science Foundation of China-Guangdong Joint Fund, Sanming Project of Medicine in Shenzen Municipality, Shenzhen High-level Hospital Construction Fund.
Abstract (Originalsprache)
PTPRQ plays an important role in the development of inner ear hair cell stereocilia. While many autosomal recessive variants in PTPRQ have been identified as the pathogenic cause for nonsyndromic hearing loss (DFNB84A), so far only one autosomal dominant PTPRQ variant, c.6881G>A (p.Trp2294*), has been reported for late‐onset, mild‐to‐severe hearing loss (DFNA73). By using targeted next‐generation sequencing, this study identified a novel PTPRQ truncating pathogenic variant, c.3697del (p.Leu1233Phefs*11), from a Chinese Han family that co‐segregated with autosomal dominant, postlingual, progressive hearing loss. A Ptprq ‐3700del knock‐in mouse model was generated by CRISPR‐Cas9 and characterized for its hearing function and inner ear morphology. While the homozygous knock‐in mice exhibit profound hearing loss at all frequencies at the age of 3 weeks, the heterozygous mutant mice resemble the human patients in mild, progressive hearing loss from age 3 to 12 weeks, primarily affecting high frequencies. At this stage, the homozygous knock‐in mice have a normal hair cell count but disorganized stereocilia. Cochlear proteosome analysis of the homozygous mutant mice revealed differentially expressed genes and pathways involved in oxidative phosphorylation, regulation of angiogenesis and synaptic vesicle cycling. Our study provides a valuable animal model for further functional studies of the pathogenic mechanisms underlying DFNA73.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
- Department of Obstetrics and Gynecology, Shanghai Putuo Maternity and Infant Hospital, Shanghai, China.
- Department of Medicine, Shenzhen University, Shenzhen, Guangdong, China.
- PKU-Shenzhen Clinical Institute of Shantou University Medical College, Shenzhen, Guangdong, China.
Förderung
- National Natural Science Foundation of China-Guangdong Joint Fund
- Sanming Project of Medicine in Shenzen Municipality
- Shenzhen High-level Hospital Construction Fund
- Shanghai Putuo District Health System Science and Technology Innovation Project
Zitieren
APA
Zhou, Y., Yin, N., Ji, L., Lu, X., Yang, W., Ye, W., Du, W., Li, Y., Hu, H., & Mei, X. (2025). A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice. Clinical Genetics. https://doi.org/10.1111/cge.14634
Vancouver
Zhou Y, Yin N, Ji L, Lu X, Yang W, Ye W, et al. A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice. Clinical Genetics. 2025. doi:10.1111/cge.14634
BibTeX
@article{Zhou2025,
author = {Zhou, Yaqi and Yin, Na and Ji, Lingchao and Lu, Xiaochan and Yang, Weiqiang and Ye, Weiping and Du, Wenhui and Li, Ya and Hu, Hongyi and Mei, Xueshuang},
title = {A Novel PTPRQ c.3697del Variant Causes Autosomal Dominant Progressive Hearing Loss in Both Humans and Mice},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14634}
}
EUVIMED